FR2824269B1 - Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras - Google Patents

Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras

Info

Publication number
FR2824269B1
FR2824269B1 FR0111377A FR0111377A FR2824269B1 FR 2824269 B1 FR2824269 B1 FR 2824269B1 FR 0111377 A FR0111377 A FR 0111377A FR 0111377 A FR0111377 A FR 0111377A FR 2824269 B1 FR2824269 B1 FR 2824269B1
Authority
FR
France
Prior art keywords
surfactants
composition consisting
adjuvant composition
body fats
hlb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0111377A
Other languages
English (en)
Other versions
FR2824269A1 (fr
Inventor
Laurent Dupuis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR0111377A priority Critical patent/FR2824269B1/fr
Publication of FR2824269A1 publication Critical patent/FR2824269A1/fr
Application granted granted Critical
Publication of FR2824269B1 publication Critical patent/FR2824269B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR0111377A 2001-09-03 2001-09-03 Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras Expired - Fee Related FR2824269B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0111377A FR2824269B1 (fr) 2001-09-03 2001-09-03 Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111377A FR2824269B1 (fr) 2001-09-03 2001-09-03 Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras

Publications (2)

Publication Number Publication Date
FR2824269A1 FR2824269A1 (fr) 2002-11-08
FR2824269B1 true FR2824269B1 (fr) 2012-03-02

Family

ID=8866911

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111377A Expired - Fee Related FR2824269B1 (fr) 2001-09-03 2001-09-03 Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras

Country Status (1)

Country Link
FR (1) FR2824269B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2533581C (fr) 2003-07-24 2012-05-08 Merial Limited Nouvelles formulations de vaccin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
JPH0681731B2 (ja) * 1986-07-31 1994-10-19 株式会社微生物化学研究所 動物用ワクチン
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
CA2307000C (fr) * 1997-10-17 2011-01-04 Richard Buchta Vaccins veterinaires
WO2000037101A1 (fr) * 1998-12-21 2000-06-29 Akzo Nobel N.V. Methode de production de vaccins inactives associes a une emulsion eau dans huile adjuvante
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン

Also Published As

Publication number Publication date
FR2824269A1 (fr) 2002-11-08

Similar Documents

Publication Publication Date Title
MX2007007305A (es) Composiciones para limpiar la piel que se retiran por enjuague o con un pano.
HK1225311A1 (zh) 透皮或透粘膜應用活性劑的用途和製劑
PL370888A1 (en) Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
MA27030A1 (fr) Composition d'inhibiteur de cyclo-oxygenase-2 selectif apte a la penetration dermique
DE60239797D1 (de) Zusammensetzungen aus hypotensivem lipid (prostaglandin) und timolol sowie deren verwendungszwecke
EP1744764A4 (fr) Formulations a vecteur intracellulaires pour anthracycliniques et analogues cytidiniques
NO20016173D0 (no) Gipssammensetninger og fremgangsmåter ved fremstilling derav
AU2002257325A1 (en) Cleavable surfactants and methods of use thereof
AU1788802A (en) Extended duration insect repellent composition and method of application to the skin
AR028570A1 (es) Composiciones de polipcptidos tnxicas contra insectos anthonomus y mctodos para el uso de las mismas
ID29643A (id) Komposisi-komposisi lelehan kanji yang dapat diproses
EP1254195A4 (fr) Compositions de degivrage et procedes de mise en oeuvre
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
DE69818586D1 (de) Emulgierende Zusammensetzung aus Polyglycosiden und Fettalkohol
AU2003301240A8 (en) Skin cleanser compositions and methods of use
ZA200502613B (en) Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
AU2002350034A1 (en) Use of thermoregulatory material to improve exercise performance
AU2002219804A1 (en) Water-in-oil insect repellent composition and method of application to the skin
AU2001280721A1 (en) Compositions of iodonium compounds and methods and uses thereof
FR2824269B1 (fr) Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras
PL340833A1 (en) Application of polyoxyl fatty alcohol alkyl ethers in compositions to be used in agriculture
FR2858771B1 (fr) Association d'agents actifs extraits d'algues et les compositions cosmetiques comprenant cette association
ITMI20022518A1 (it) Dispositivo e procedimento per minimizzare ritardo di
ES2196645T3 (es) Composiciones transparentes para el cuidado de la piel.
FR2800280B1 (fr) Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

ST Notification of lapse

Effective date: 20210105